Death (and taxes?)
Hospices are fundamental to end of life care, and the broader shift ‘from hospital to community’.
Beating the backlog: Meeting the waiting list challenge
The NHS waiting list in England must halve to reach waiting time targets.
Transforming Hospital Planning with an Open-Source Demand and Capacity Model
We are proud to announce the open-sourcing of a demand and capacity model, developed with the New Hospitals Programme, to transform NHS hospital planning with transparency, collaboration, and efficiency.
‘Internal Consultancy’: INSIGHTS from evidence and experience
In this blog, our Head of Policy, Fraser Battye, shares his reflections on a recent ‘SU INSIGHTS’ event on the ‘Internal Consultancy’
Charisma
In this long read, which first appeared in the HSJ, Fraser Battye - our Head of Policy – looks at the role of charisma and innovation in the way that NHS resources are allocated.
Ara Darzi, Wes Streeting and English health policy. Part 2: cutting the knot
Following on from part one, Fraser continues exploring the Gordian Knot of English health policy.
Ara Darzi, Wes Streeting and English health policy. Part 1: the Gordian Knot
Health policy is not at a crossroads, it is in a bind. Strands so entangled, so complex they resemble a Gordian knot. Can this knot be untied?
Want to ease pressure in urgent care? Simply cut community services!?!
What should decision makers do with analysis that challenges deeply held assumptions? In this blog, Fraser Battye reflects on a surprising recent finding about community services.
Playing our part in conversations about death
“Dad, why are all your ‘peptalks’ about death?” Children can be a source of fundamental insight. They seem to specialise in feedback of the unvarnished, unmediated and fully caffeinated variety. The kind of feedback that cuts straight to it. My youngest daughter, mid-way through our sunny walk down the hill to school, pressed on: “And you wear black all the time. You look like a crow…” Fundamental insight, and now fashion advice. This was quite the school run.
Diagnosing harms?
All medicines are poisons. Everything that cures could kill if administered in the wrong doses, to the wrong people, at the wrong times, in the wrong ways.
What matters when waiting? – involving the public in NHS waiting list prioritisation
As the NHS emerged out of the pandemic, it was confronted with the challenge of not only recovery of unprecedented waiting lists, but with inequalities which required attention. NHS leaders challenged providers to restore inclusively and at University Hospitals Coventry and Warwickshire NHS Trust, we have developed a way of doing just that, whilst simultaneously reducing waiting times for all.
Inequalities in access to healthcare - what’s our next move?
Our research, published in the Lancet Regional Health Europe, highlights substantial inequities in access to elective hip replacement surgery. We found no evidence that these inequities reduced between 2006 and 2016.
Treating people on waiting lists: who decides what is fair?
Waiting lists for elective care are in the news. The national plan has been issued, with the expectation that lists will continue to rise for some years - and that long waiting will not disappear anytime soon. Addressing this ‘backlog’ will remain a fundamental challenge for some time to come.
Decisions to admit patients are not solely determined by clinical risk
Whether or not to admit a patient is one of the most routine yet important decisions a doctor in an Emergency Department
How can analysis help clinicians improve services? Interview with Dr Anna Lock
Dr Anna Lock, Justine Wiltshire and Lucy Hawkins reflect on the Strategy Unit's innovative end of life care analysis. How can this work help clinicians to improve services?
End of Life analysis: what next? A perspective from Catherine Walshe
‘In this world nothing can be said to be certain, except death and taxes’.
End of Life analysis: what next? A perspective from Seamus O'Mahony
In this blog, the author of ‘The Way We Die Now’ - Seamus O’Mahony – sets our findings into a broader context. He also examines one topic raised in our analysis: chemotherapy at the end of life.
Why are deaths set to rise?
In our recent analysis of healthcare use in the last 2 years of life, we point out an important change that’s taking place to life and death in the UK.